Advice

in the absence of a submission from the holder of the marketing authorisation

bromfenac (Yellox ®) eye drops are not recommended for use within NHS Scotland.

Indication: treatment of postoperative ocular inflammation following cataract extraction in adults.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Download detailed advice38KB (PDF)

Download

Medicine details

Medicine name:
bromfenac (Yellox)
SMC ID:
740/11
Indication:
Treatment of postoperative ocular inflammation following cataract extraction in adults.
Pharmaceutical company
Bausch and Lomb GmbH
BNF chapter
Eye
Submission type
Non submission
Status
Not recommended
Date advice published
10 October 2011